Skip to main content

Roundup Lawyers Accuse Bayer of ‘Pay to Appeal Scheme’

Roundup Lawyers Accuse Bayer of ‘Pay to Appeal Scheme’

Roundup Lawyers Accuse Bayer of ‘Pay to Appeal Scheme’

Introduction

In a letter to the Eleventh Circuit, third-party attorneys said that Bayer is trying to dismiss thousands of Roundup lawsuits by paying the plaintiff who alleged the weedkiller caused his cancer.

The plaintiff will need to pay $100,000 under the "pay-to-appeal scheme" if he decides to drop the appeal. The attorneys for the plaintiff argued that Monsanto failed to warn that Roundup causes cancer, and the appeal challenges Bayer's argument that federal law preempts state law claims.

All the attorneys across the nation who represent Roundup plaintiffs claim that the company completely failed to issue the warning of Roundup causing cancer.

This is the first case that Monsanto has won on the grounds of failure to warn the issue of Roundup causing cancer. The company even admitted that it paid the plaintiff to appeal the issue to court. The counsel for the plaintiff and Monsanto agreed on a settlement only if the appeal limits to failure to warn the issue.

Attorneys for the plaintiff admitted that if there were no agreement, he wouldn't have prosecuted the case at the district court level due to the lack of scientific evidence to support his particular cancer allegations.

The spokesperson for Bayer stated that the company wants to maintain transparency in appealing about the failure-to-warn about Roundup in the lawsuits on federal preemption grounds. The company has already resolved tens of thousands of claims, and its ultimate goal is to prevent new cases.

Bayer is constantly facing litigations since 2018 after purchasing Monsanto CoIt has even agreed to pay $11.6 billion to resolve Roundup lawsuits from about 125,000 consumers and farmers in the U.S.

U.S. District Judge Vince Chhabria is overseeing all the Roundup lawsuits in the Northern District of California under MDL No. 2741.

Comments

Restricted HTML

  • Allowed HTML tags: <a href hreflang> <em> <strong> <cite> <blockquote cite> <code> <ul type> <ol start type> <li> <dl> <dt> <dd> <h2 id> <h3 id> <h4 id> <h5 id> <h6 id>
  • Lines and paragraphs break automatically.
  • Web page addresses and email addresses turn into links automatically.

Latest News

NC to Get $150M to Boost Opioid Treatment, Recovery

Categories: Opioids

North Carolina will receive an additional $150 million from Purdue Pharma and the Sackler family as part of a national $7.4 billion settlement related to the opioid

SRI Gets FDA OK for High-Dose Naloxone Trial

Categories: Opioids

SRI has received authorization from the U.S. Food and Drug Administration (FDA) to begin Phase 1 clinical trials of a new, high-dose injectable naloxone formulation.

The approval was granted under an Investigational New Drug (IND)…

Spokane County to Get $5M in New Opioid Settlement

Categories: Opioids

Jurisdictions within Spokane County are set to receive nearly $4.7 million as part of a sweeping $7.4 billion nationwide settlement with Purdue Pharma and its owners, the Sackler family.

The agreement addresses the company’s role in fueling…

✍️ FREE—3000 Pages Medical Record Review Trial!                
No Contract. No Risk—Fully Customized, Free!

Only 10 Firms Accepted—Offer Ends June 30!